Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Upcoming Drug Candidate Trial Rides Swell of Groundbreaking Psychedelic Medicine Efforts
Tryp Therapeutics is a pharmaceutical company focused on developing new potential treatments for medical conditions with unmet needsThe company’s current lead candidates for drug development are a synthetic psychedelic for treating fibromyalgia and eating disordersTryp’s efforts to develop a psychedelic drug candidate are part of a broader scientific movement to use various mind-altering drugs to treat select neurological conditions when paired with the care of…